Utah Medical Products IncUTMD
Price$74.05Intrinsic value$58.5321% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $36.1M-11.7% YoYTTM through 30 Jun 2026
Net Income $10.5M-24.4% YoYTTM through 30 Jun 2026
Free Cash Flow $11.4MTTM through 30 Jun 2026

Margins

Current
Gross Margin57.1%
EBITDA Margin36.1%
Operating Margin29.6%
Net Margin29.0%

Returns

9.5%ROE
9.2%ROA
9.5%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio37.60x
Net Debt-$85.8Mnet cash position
Cash & Equivalents$87.5M

Quality Metrics

Altman Z-Score60.67
Piotroski F-Score5 / 9
FCF Margin31.7%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $38.5M
Diluted EPS$3.28TTM
'19'20'21'22'23'24'25
FY2025: $3.48

Dividend

$0.62Per share, FY20260.81%Yield-26.3%5-yr growth

Capital Allocation

R&D Spend$687K
Capex Intensity1.1%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.